93N-19313-46236
1 vaccination
6 coded responses
8 check-ins
6 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 197 / DE
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2021-01-04
Registered in v-safe
-
2021-01-05
Health check-in — day 7, dose 1Feeling: Good · Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitAdult check-in
-
2021-01-05
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-12
Survey response — day 14, dose 1MedDRA: Petechiae, Rash — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Since my last check I had a petechial rash that spread down both my legs to my feet. I had more petechiae under both my arms, left hand and lower forearm. My right lower inner arm and my abdomenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-19
Survey response — day 21, dose 1MedDRA: Blood pressure increased — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: My blood pressure is elevated 170/90 HR 104MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-26
Survey response — day 28, dose 1MedDRA: Dyspnoea, Ear swelling, Palpitations — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: SOB, palpitations, swelling by earsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Report sent to call center — day 28, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-04
-
2021-02-04
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-02-09
Survey response — day 42, dose 1MedDRA: Back pain, Inflammation, Petechiae — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Petechial rash continues both legs arms back side and face. Inflammation below ears. Low back pain. White first digit left footMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-29
Survey response — 6 months, dose 1MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: PericarditisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-29
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-01
Call successfulParticipant prefers to complete VAERS report online
-
2021-12-29
Survey response — 12 months, dose 1MedDRA: Glossodynia, Oral pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Runny nose congestion and sore tongue and roof of my mouthMedDRA releases: 2024-11 · check-in free text available
-
2021-12-29
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-03
-
2022-01-03
Callback requested for01:00PM ET
-
2022-01-03
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech |
Call center
6 call center cases
6 successful
VAERS report filed, before or during a call: 5
Free text
Release 1 — day 14, dose 1
Symptoms: Since my last check I had a petechial rash that spread down both my legs to my feet. I had more petechiae under both my arms, left hand and lower forearm. My right lower inner arm and my abdomen
Release 2 — day 21, dose 1
Symptoms: My blood pressure is elevated 170/90 HR 104
Release 2 — day 28, dose 1
Symptoms: SOB, palpitations, swelling by ears
Release 3 — day 42, dose 1
Symptoms: Petechial rash continues both legs arms back side and face. Inflammation below ears. Low back pain. White first digit left foot
Release 9 — 6 months, dose 1
Symptoms: Pericarditis
Release 10 — 12 months, dose 1
Symptoms: Runny nose congestion and sore tongue and roof of my mouth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Blood pressure increased | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Ear swelling | ✓ | ✓ | ✓ |
| SD | Glossodynia | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Oral pain | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SD | Petechiae | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release